Abstract:Mitochondrial DNA (mtDNA) encodes essential subunits of the oxidative phosphorylation system, but is also a major damage-associated molecular pattern (DAMP) that engages innate immune sensors when released into the cytoplasm, outside of cells or into circulation. As a DAMP, mtDNA not only contributes to anti-viral resistance, but also causes pathogenic inflammation in many disease contexts. Cells experiencing mtDNA stress caused by depletion of the mtDNA-packaging protein, transcription factor A, mitochondrial (TFAM) or during herpes simplex virus-1 infection exhibit elongated mitochondria, enlargement of nucleoids (mtDNA–protein complexes) and activation of cGAS–STING innate immune signalling via mtDNA released into the cytoplasm. However, the relationship among aberrant mitochondria and nucleoid dynamics, mtDNA release and cGAS–STING activation remains unclear. Here we show that, under a variety of mtDNA replication stress conditions and during herpes simplex virus-1 infection, enlarged nucleoids that remain bound to TFAM exit mitochondria. Enlarged nucleoids arise from mtDNA experiencing replication stress, which causes nucleoid clustering via a block in mitochondrial fission at a stage when endoplasmic reticulum actin polymerization would normally commence, defining a fission checkpoint that ensures mtDNA has completed replication and is competent for segregation into daughter mitochondria. Chronic engagement of this checkpoint results in enlarged nucleoids trafficking into early and then late endosomes for disposal. Endosomal rupture during transit through this endosomal pathway ultimately causes mtDNA-mediated cGAS–STING activation. Thus, we propose that replication-incompetent nucleoids are selectively eliminated by an adaptive mitochondria–endosomal quality control pathway that is prone to innate immune system activation, which might represent a therapeutic target to prevent mtDNA-mediated inflammation during viral infection and other pathogenic states.

Genome Replication Is Associated With Release of Immunogenic DNA Waste

Activation of cyclic GMP-AMP synthase by self-DNA causes autoimmune diseases

cGAS activation in classical dendritic cells causes autoimmunity in TREX1-deficient mice

Aicardi–Goutières Syndrome Protein TREX1 Suppresses L1 and Maintains Genome Integrity Through Exonuclease-Independent ORF1p Depletion

T‐Rex escaped from the cytosolic park: Re‐thinking the impact of TREX1 exonuclease deficiencies on genomic stability

RPA and Rad51 constitute a cell intrinsic mechanism to protect the cytosol from self DNA

Adaptive inhibition of CGAS signaling by TREX1

cGAS activation causes lupus-like autoimmune disorders in a TREX1 mutant mouse model

Mutations in the non-catalytic polyproline motif destabilize TREX1 and amplify cGAS-STING signaling

ER-directed TREX1 limits cGAS activation at micronuclei

The exonuclease TREX1 constitutes an innate immune checkpoint limiting cGAS/STING-mediated antitumor immunity

Abstract LB361: The exonuclease TREX1 constitutes an innate immune checkpoint limiting cGAS/STING-mediated anti-tumor immunity

Structural basis of human TREX1 DNA degradation and autoimmune disease

Mitochondrial DNA replication stress triggers a pro-inflammatory endosomal pathway of nucleoid disposal

TREX1 as a Novel Immunotherapeutic Target

R-loops and impaired autophagy trigger cGAS-dependent inflammation via micronuclei formation in Senataxin-deficient cells

Selective inflammation of the tumor microenvironment and invigorated T cell-mediated tumor control upon induced systemic inactivation of TREX1

cGAS surveillance of micronuclei links genome instability to innate immunity

DNA-PK deficiency potentiates cGAS-mediated antiviral innate immunity

TREX1 plays multiple roles in human diseases